The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
An approach to remove albumin for the proteomic analysis of low abundance biomarkers in human serum
Abstract
Proteomic technologies are being used to discover and identify disease‐associated biomarkers. The application of these technologies in the search for potential diagnostic/prognostic biomarkers in the serum of patients has been limited by the presence of highly abundant albumin and immunoglobulins that constitute approximately 60–97% of the total serum proteins. The purpose of the study was to evaluate whether treatment of human serum with Affi‐Gel Blue alone or in combination with Protein A (Aurum serum protein mini kit, Bio‐Rad) before two‐dimensional gel electrophoresis (2‐DE) analysis removed high abundance proteins to allow the visualization of low abundant proteins. Serum samples were treated with either Affi‐Gel Blue or Aurum kit and then subjected to 2‐DE using 11 cm, pH 4–7 isoelectric focussing strips for the first dimension and 10% sodium dodecyl sulfate‐polyacrylamide gel electrophoresis for second dimension. Protein spots were visualized using a fluorescent protein dye (SYPRO Ruby, Bio‐Rad). Comparison between treatment methods showed significant removal of albumin by both Affi‐Gel Blue and Aurum kit and considerable differences in the protein profile of the gels after each treatment. Direct comparison between treatments revealed twenty‐eight protein spots unique to Affi‐Gel Blue while only two spots were unique after Aurum kit treatment. Unique spots in Affi‐Gel Blue and Aurum kit treated serum were not visualized in untreated serum. Sixteen hours of Affi‐Gel Blue treatment resulted in enhanced visualization of fifty‐three protein spots by two‐fold, thirty‐one by five‐fold, twelve by ten‐fold and six by twenty‐fold. In parallel after Aurum kit treatment two‐, five‐, ten‐ and twenty‐fold enhancements of thirty, thirteen, eight and five protein spots, respectively, were observed. The pattern of increased visualization of protein spots with both treatment methods was similar. In conclusion, treatment of serum samples with Affi‐Gel Blue or Aurum kit before 2‐DE analysis can be used to remove high abundance proteins in order to increase the detection sensitivity of proteins present in low abundance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Use of proteomic patterns in serum to identify ovarian cancer
Petricoin, E. F., Ardekani, A. M., Hitt, B. A., Levine, P. J., Fusaro, V. A., Steinberg, S. M., Mills, G. B., Simone, C., Fishman, D. A., Kohn, E. C., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07746-2 · Cited by 3,236
Cited by
Exosomes in bodily fluids are a highly stable resource of disease biomarkers
Boukouris, S., & Mathivanan, S. (2015) · PROTEOMICS – Clinical Applications · doi:10.1002/prca.201400114 · Cited by 586
Human body fluid proteome analysis
Hu, S., Loo, J. A., & Wong, D. T. (2006) · PROTEOMICS · doi:10.1002/pmic.200600284 · Cited by 533
Depletion of Abundant Plasma Proteins and Limitations of Plasma Proteomics
Tu, C., Rudnick, P. A., Martinez, M. Y., Cheek, K. L., Stein, S. E., Slebos, R. J. C., & Liebler, D. C. (2010) · Journal of Proteome Research · doi:10.1021/pr100646w · Cited by 390
Björhall, K., Miliotis, T., & Davidsson, P. (2005) · PROTEOMICS · doi:10.1002/pmic.200400900 · Cited by 384
Echan, L. A., Tang, H., Ali‐Khan, N., Lee, K., & Speicher, D. W. (2005) · PROTEOMICS · doi:10.1002/pmic.200401228 · Cited by 353
Metadata
- Authors
- Ahmed, N., Barker, G., Oliva, K., Garfin, D., Talmadge, K., Georgiou, H., Quinn, M., & Rice, G.
- Venue
- PROTEOMICS
- Publisher
- Wiley
- Published
- 2003-10
- Volume
- 3
- Issue
- 10
- Pages
- 1980-1987
- ISSN
- 1615-9853 (ISSN-L)
- 1615-9861
- OpenAlex
- W2088261915
- Cited by
- 197
- References
- 1
- FWCI
- 7.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.